This is in keeping with our findings that higher stage, nonacinar and nonlepidic adenocarcinoma subtype, sublobar resection, positive resection margins, and lymphovascular invasion were associated with increased recurrence risk among patients with EGFR-positive NSCLC and distinct from wildtype EGFR NSCLC. This evidence concerns the gene EGFR and adenocarcinoma.